For instance, March 18, 2025 will be mentioned according to the Hindu calendar as Chaitra Shukla Chaturthi, Vikram samvat 2082, Saka samvat 1946, Phalguna 27, an official release here said. Vikram ...
For example, March 18, 2025, will be recorded in the Hindu calendar as Chaitra Shukla Chaturthi, Vikram Samvat 2082, Saka Samvat 1946, and Phalguna 27. Dhami further said that Vikram Samvat is an ...
For instance, March 18, 2025 will be mentioned according to the Hindu calendar as Chaitra Shukla Chaturthi, Vikram samvat 2082, Saka samvat 1946, Phalguna 27, an official release here said.
Bigg Boss 13 remains memorable with its prominent personalities like Sidharth Shukla, Shehnaaz Gill, and others. Madhurima Tuli recently shared her fond memories of Sidharth, emphasizing their ...
There are high expectations for this film as Vikram collaborated with Arun Kumar for the first time, and the movie is coming out after his recent epic film 'Thangalaan.' For Thangalaan ...
Arv­inas and Pfiz­er’s tar­get­ed pro­tein de­grad­er has not man­aged to dis­tin­guish it­self from oth­er, sim­i­lar breast can­cer drugs, ac­cord­ing to piv­otal da­ta re­ ...
Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...
Arvinas’ stock took a 43% tumble on the news, and analysts are downcast on the drug’s prospects. Pfizer and Arvinas’ investigational PRTOAC degrader vepdegestrant can improve progression-free survival ...
Himachal Pradesh Governor Shiv Pratap Shukla Monday acknowledged that the state government has been grappling with financial difficulties since the rollback of Goods and Services Tax (GST) ...
Bigg Boss season 13 remains one of the most iconic seasons of the reality show, featuring a talented ensemble cast, including Sidharth Shukla, Shehnaaz Gill, and Rashami Desai. The season's memorable ...
Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ups and downs in between, after it took a hammering in the past couple ...
Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...